JS
At a glance
Registered since
2024
Senate LDA system
Clients
29
last 3 years
Filings
85
9 agencies contacted
Activity
filings by quarter
Works on
Background
Government experience
Counsel
House E&C Cmte, Oversight Subcommittee; Senior Counsel, House E&C Cmte, Health Subcommittee; Intern, House E&C
Disclosed on LD-2 filings
Career
BG
Specific issues
Provide strategic counsel and advocacy on issues relating to biopharmaceuticals for rare diseases driven by genetic causes generally, or BioMarin Pharmaceutical specifically.
Provide strategic counsel and advocacy for issues related to policies impacting the pharmaceutical industry generally including drug shortages, patient out of pocket costs, supply chain, PBM policies, kidney care policies, Inflation Reduction Act (IRA) implementation issues, the Maintaining Investments in New Innovation (MINI) Act S. 476/H.R.5547, and biopharma innovation policies.
Provide strategic counsel and advocacy for issues related to the non-human primate supply chain for research and practical applications of invitro alternatives in research
Provide strategic guidance and advocacy on issues related to regulation of, access to, and reimbursement for regenerative medicine products, and any other issues related to the Alliance for Regenerative Medicine specifically.
Provide guidance and advocacy with regard to regulations and legislation that could impact nonprofit initiatives generally, patient assistance initiatives, rare disease patients and The Assistance Fund specifically.
Provide guidance and advocacy with regard to regulations and legislation that could impact the medical device industry generally, and Stryker Corporation specifically.
Clients
Filing history
EDWARDS LIFESCIENCES LLC
GLAXOSMITHKLINE, INC
PFIZER, INC
NATIONAL RESILIENCE, INC.
ABIOMED INC
BIOMARIN PHARMACEUTICAL INC.
WALGREEN CO.
CHARLES RIVER LABORATORIES
BIOTECHNOLOGY INNOVATION ORGANIZATION
PTC THERAPEUTICS
SENIOR CARE PHARMACY COALITION
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA